Summary of China Cosmetics Conference Call Industry Overview - The focus is on the **anti-aging beauty market** in China, which includes traditional anti-aging skincare, medical aesthetics (MA), and dermocosmetics. - The market is expected to grow at a **high single-digit CAGR** over the period from 2025 to 2030, with medical aesthetics and dermocosmetics leading at **9%** and anti-aging skincare at **6%** [1][22]. Key Insights Market Penetration and Demographics - The current penetration of the MA market in China is low, estimated at **5%** for the core consumer group aged **20-60**, compared to **10%-20%** in developed markets. It is expected to rise to **8%** by **2030E**, supporting a **10% CAGR** for MA users [2][22]. - Anti-aging skincare is seeing earlier adoption among younger consumers, with approximately **40%** of this demographic engaging with the category, which is expected to drive further expansion [2][22]. Pricing Dynamics - More resilient pricing is anticipated from **2026E** due to stricter regulations and healthier competition, with limited supply tailwinds favoring recombinant collagen. The MA market has experienced sharp price reductions due to intense competition, but future pricing is expected to stabilize [3][22]. - Factors contributing to this stabilization include more accessible pricing in China and a narrower price gap with Korea following recent policy changes [3][22]. Company Recommendations - **Forest Cabin** is initiated with a **Buy** rating, expected to benefit from growth in oil-based anti-aging skincare, with a projected **48% sales CAGR** from **2022-2025E** and **32%/29% sales/NP CAGR** from **2025-2028E** [4][22]. - **Giant Biogene** is also rated **Buy** due to its integrated value chain from MA to dermocosmetics, enhancing R&D and brand recognition [4][22]. - **Proya** is viewed as a domestic leader in the anti-aging sector but is rated **Neutral** pending further evidence of the new management's execution track record [4][22]. Market Growth Projections - The overall anti-aging market in China is projected to grow from **RMB 214 billion** in **2024E** to **RMB 398 billion** by **2030E**, reflecting a **CAGR of 8%** [20][22]. - Medical aesthetics is expected to contribute significantly to this growth, with a **10.3% volume CAGR** over the same period, despite ongoing pricing pressures in certain categories [17][22]. Additional Insights - The report emphasizes the importance of companies with larger sales exposure to growth segments, stronger market positions, and better operational execution, including R&D capabilities [10][22]. - The anti-aging skincare segment is projected to see a shift towards functionalities beyond basic moisturizing, with penetration expected to increase from **25.6% to 29.0%** from **2025 to 2030E** [19][22]. Conclusion - The anti-aging beauty market in China presents significant growth opportunities driven by demographic shifts, evolving consumer perceptions, and technological advancements. Companies like Forest Cabin and Giant Biogene are well-positioned to capitalize on these trends, while pricing dynamics and market penetration will play crucial roles in shaping the competitive landscape.

Core Viewpoint - Guangdong Marubi Biotechnology Co., Ltd. has submitted an application for listing on the Hong Kong Stock Exchange, with Goldman Sachs and CITIC Securities as joint sponsors, highlighting its position as a leading Chinese beauty company focused on anti-aging solutions [1] Company Overview - Marubi Biotechnology specializes in providing anti-aging skincare solutions and has over 20 years of experience in the industry, driven by synthetic biology technology [1] - The company emphasizes research and development, particularly in core technologies such as recombinant collagen, to innovate skincare products with anti-wrinkle, firming, and repairing effects [1] Market Position - According to a report by Frost & Sullivan, Marubi is the third largest beauty company in China in the segment of recombinant collagen skincare products, based on retail sales projected for 2024 [1]

Group 1 - The core viewpoint of the article is that Guangdong Marubi Biotechnology Co., Ltd. has submitted an application for listing on the Hong Kong Stock Exchange, with Goldman Sachs and CITIC Securities as joint sponsors [1] - Marubi Biotechnology is a leading Chinese beauty company focused on providing anti-aging solutions, leveraging synthetic biology technology and over 20 years of experience in the anti-aging skincare industry [1] - The company emphasizes research and development, particularly in core technologies such as recombinant collagen, to innovate skincare products with anti-wrinkle, firming, and repairing effects [1] Group 2 - According to a report by Frost & Sullivan, Marubi Biotechnology is the third largest beauty company in China in the recombinant collagen skincare segment, based on retail sales projected for 2024 [1]

Group 1 - The core viewpoint of the article is that Guangdong Marubi Biotechnology Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, with Goldman Sachs and CITIC Securities as joint sponsors [1] - Marubi Biotechnology is a leading Chinese beauty company focused on providing anti-aging solutions, leveraging synthetic biology technology and over 20 years of experience in the anti-aging skincare industry [1] - The company emphasizes research and development, particularly in core technologies such as recombinant collagen, to create skincare products with anti-wrinkle, firming, and repairing effects [1] Group 2 - According to a report by Frost & Sullivan, Marubi is the third largest beauty company in China in the recombinant collagen skincare segment, based on retail sales projected for 2024 [1]

Core Insights - The article highlights a significant shift in consumer health consciousness, particularly among millennials and Generation Z, leading to a transformation in the global health industry valued at over 10 trillion yuan [1][2][31] - The research identifies six key health segments with growth potential, driven by younger consumers who are redefining health practices and expanding the application of health concepts [1][14][31] Group 1: Consumer Health Priorities - 94% of Chinese consumers prioritize health as a key concern, with similar trends observed in the UK (79%) and the US (84%) [2] - 64% of Chinese consumers are willing to maintain or increase health-related spending despite economic downturns, indicating resilience in the health sector [2] - Essential health-related products, such as personal hygiene and common medications, show the highest resilience, while gym memberships may face cuts during financial strain [2] Group 2: Young Consumers and Health Trends - Approximately 42% of Chinese millennials are focusing more on health management compared to the previous year, surpassing the overall population's 36% [3] - Generation Z shows a higher concern for stress management and sexual health, while millennials prioritize heart and overall health [6][19] - The younger generation's engagement with health content on social media influences their purchasing behavior [3] Group 3: Importance of Professional Recommendations - Recommendations from family, friends, and professionals significantly influence health-related purchasing decisions, with doctors being crucial for health management and nutritionists for dietary choices [11][12] - The reliance on vertical professionals for health advice underscores the need for health companies to target specific scenarios and leverage expert endorsements [11] Group 4: Emerging Health Segments - Sleep health is a top concern for consumers, with 39% considering it "very important," and spending patterns differ between genders [15] - Gut health is gaining attention, with 69% of consumers planning to prioritize it in the next 2-3 years, driven by a shift towards "food as medicine" [16] - Stress management is increasingly relevant, particularly among younger consumers, with 36% of Generation Z feeling "always stressed" [19] Group 5: Anti-Aging and Weight Management - The demand for anti-aging products is rising, with 60% of consumers viewing healthy aging as a priority, encompassing cognitive support and chronic disease prevention [23] - Weight management remains a global focus, with over 1/8 of the population facing obesity issues, and younger consumers particularly concerned about weight [24][25] Group 6: Health Tourism - There is a growing demand for health-related travel experiences, with 91% of Chinese consumers participating in face-to-face yoga classes and 83% in non-invasive body care [28][29] - The trend towards experiential consumption in health tourism is expected to continue, with younger generations showing a strong interest in such activities [28][30] Group 7: Strategic Recommendations for Health Companies - Companies should focus on creating integrated solutions that address consumer health needs across various categories, emphasizing professional credibility and value delivery [31][33] - Highlighting scientific backing and expert recommendations can differentiate brands and enhance consumer trust [31][33] - Providing clear value beyond pricing, including product quality and effectiveness, is essential for success in the evolving health market [31][33]